Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Adaptate, Affiris, Amyris, Astellas, Basilea, Biologics of Jemincare, Biontech, Biorchestra, Clear Creek, Coherus, Cumberland, Dinaqor, Dotbio, Eisai, Everest Medicines, Evotec, Frontier Biotechnologies, Genentech, Gilead Sciences, Glaxosmithkline, Green Cross, Iksuda, Immunitybio, Insilico Medicine, Johnson & Johnson, Junshi, Kyowa Kirin, Legochem, Liscure, McQuade Center for Strategic R&D, Mdimune, Merck, Mindset, Otsuka, PCI, Pfizer, Prism Biolab, Qiagen, Revelar, Rivaara Immune, Roche, Roivant Sciences, Santhera, SK, Sperogenix, Synairgen, Syneurx International, Takeda, Tonix, Twist Bioscience, Vir.

Biopharmas in Asia-Pacific raising money in public or private financings: Accro, Atom Bioscience, Bionomics, Cellusion, Chance, Hanmi, Innate, Spectrum.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Abionyx, Akeso, Alphamab Oncology, Astrazeneca, Beigene, Biontech, CSPC, Cstone, Everest Medicines, Moderna, Novavax, Nrx, Organon, Paxmedica, Pfizer, Samsung Bioepis, Simcere, Zai Lab.

New hires and promotions in the biopharma industry in Asia-Pacific, including: Carsgen, Overland.

New hires and promotions in the biopharma industry in Asia-Pacific, including: Hightide, JW, Zenas.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Akeso, Antengene, Astrazeneca, Bharat Biotech, Bio-Thera Solutions, Daiichi Sankyo, Dawnrays, Kiniksa, Kintor, Luye, Novavax, Nykode, Ocugen, Pharmabcine, Pluristem, Revive, Ribomic.

New hires and promotions in the biopharma industry in Asia-Pacific, including: Biosion, Opthea.